LIPELLA PHARMACEUTICALS INC. LIPO Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001753926-25-000818
cik 1347242
name LIPELLA PHARMACEUTICALS INC.
sic 2834
countryba US
stprba PA
cityba PITTSBURGH
zipba 15208
bas1 400 N LEXINGTON ST
bas2 STE LL103
baph 412-901-0315
countryma US
stprma PA
cityma PITTSBURGH
zipma 15208
mas1 400 N LEXINGTON ST
mas2 STE LL103
countryinc US
stprinc DE
ein 000000000
former LIPELLA PHARMACEUTICALS INC
changed 20051219
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250514
accepted 2025-05-14 17:06:00.0
prevrpt 0
detail 1
instance g084803_10q_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001753926-25-000818 20250331 Revenues 129390.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Accounts Receivable Net Current USD 0 us-gaap/2024
0001753926-25-000818 20241231 Accrued Liabilities Current 237886.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Assets Current 2617252.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2105299.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Earnings Per Share Diluted -1.3100 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Furniture And Fixtures Gross 140294.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 General And Administrative Expense 49289.0000 USD 1 us-gaap/2024 Business Segments= Facility And Other Overhead;
0001753926-25-000818 20240331 General And Administrative Expense 312647.0000 USD 1 us-gaap/2024 Business Segments= Outside Services;
0001753926-25-000818 20250331 Income Taxes Paid Net USD 1 us-gaap/2024
0001753926-25-000818 20250331 Increase Decrease In Deferred Liabilities 21689.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Shares Net Of Issuance Costs 46025.0000 shares 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Issuance Of Stock And Warrants For Services Or Claims USD 1 us-gaap/2024
0001753926-25-000818 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20250331 Net Income Loss -1306523.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Operating Right Of Use Asset1 215.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Shares Outstanding 35330.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Subsequent Event Type= Subsequent Event;
0001753926-25-000818 20250331 Preferred Stock Shares Outstanding 260185.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Subsequent Event Type= Subsequent Event;
0001753926-25-000818 20250430 Preferred Stock Shares Outstanding 9866.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Subsequent Event Type= Subsequent Event;
0001753926-25-000818 20240331 Proceeds From Issuance Of Common Stock 200000.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Property Plant And Equipment Net 9864.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Research And Development Expense 842600.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Research And Development Expense USD 1 us-gaap/2024 Business Segments= Stock Option Expense;
0001753926-25-000818 20240331 Revenues 145880.0000 USD 1 us-gaap/2024 Product Or Service= Grantrevenues;
0001753926-25-000818 20241231 Shares Outstanding 25975.0000 shares 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20241231 Stockholders Equity 121.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Stock Issued During Period Value Issuance Of Common Stocks USD 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20240331 Warrants Converted To Common Stock 6.0000 USD 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20240331 Warrants Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Retained Earnings;
0001753926-25-000818 20250331 Warrants Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Weighted Average Number Of Diluted Shares Outstanding 2056804.0000 shares 1 us-gaap/2024
0001753926-25-000818 20240331 Weighted Average Number Of Shares Outstanding Basic 911515.0000 shares 1 us-gaap/2024
0001753926-25-000818 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2184863.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Common Stock Shares Authorized 200000000.0000 shares 0 us-gaap/2024
0001753926-25-000818 20240229 Common Stock Shares Issued 55000.0000 shares 0 us-gaap/2024 Plan Name= Stock Option Plans;
0001753926-25-000818 20250331 Common Stock Shares Outstanding 2548811.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 General And Administrative Expense 520926.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 General And Administrative Expense 157118.0000 USD 1 us-gaap/2024 Business Segments= Salaries And Benefits Insurance;
0001753926-25-000818 20250331 General And Administrative Expense 463736.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Grants Receivable Current 84712.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Increase Decrease In Grants Receivable 36648.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20250331 Increase Decrease In Grants Receivable 918.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20250331 Increase Decrease In Prepaid Expense 165020.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Issuance Of Stock And Warrants For Services Or Claims 200000.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Net Cash Provided By Used In Investing Activities USD 1 us-gaap/2024
0001753926-25-000818 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20250331 Nonoperating Income Expense 21298.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Operating Income Loss -1327821.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Operating Lease Liability Current 23997.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Operating Lease Right Of Use Asset 23572.0000 USD 0 us-gaap/2024 Finite Lived Intangible Assets By Major Class= Use Rights;
0001753926-25-000818 20241231 Payroll Liability 80735.0000 USD 0 0001753926-25-000818
0001753926-25-000818 20250331 Payroll Liability 102425.0000 USD 0 0001753926-25-000818
0001753926-25-000818 20250331 Preferred Stock Shares Issued 20000000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Shares Outstanding 536959.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20240331 Research And Development Expense 224900.0000 USD 1 us-gaap/2024 Business Segments= Salaries And Benefits Insurance;
0001753926-25-000818 20240331 Revenues 145880.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Revenues 129390.0000 USD 1 us-gaap/2024 Product Or Service= Grantrevenues;
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20231231 Stockholders Equity 13468216.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20231231 Stockholders Equity 75.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20241231 Stockholders Equity -15340107.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20241231 Stockholders Equity 3.0000 USD 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Stockholders Equity 53.0000 USD 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20240331 Stock Issued During Period Value Issuance Of Common Stocks 199996.0000 USD 1 0001753926-25-000818 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20240331 Stock Issued During Period Value Issued For Services USD 1 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20240331 Stock Issued During Period Value Share Based Compensation USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3293738.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Common Stock Shares Outstanding 2548811.0000 shares 0 us-gaap/2024
0001753926-25-000818 20250331 Earnings Per Share Basic -0.6400 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Earnings Per Share Diluted -0.6400 USD 1 us-gaap/2024
0001753926-25-000818 20250331 General And Administrative Expense 229115.0000 USD 1 us-gaap/2024 Business Segments= Outside Services;
0001753926-25-000818 20250331 General And Administrative Expense USD 1 us-gaap/2024 Business Segments= Stock Option Expense;
0001753926-25-000818 20240331 Increase Decrease In Accounts Payable 155819.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Increase Decrease In Prepaid Expense 733601.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Net Of Issuance Costs 5.0000 USD 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Issuance Of Warrants To Purchase Series B Preferred Stock 9000.0000 USD 1 0001753926-25-000818 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20250331 Issuance Of Warrants To Purchase Series B Preferred Stock USD 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Net Cash Provided By Used In Financing Activities 3466275.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Net Cash Provided By Used In Investing Activities USD 1 us-gaap/2024
0001753926-25-000818 20250331 Net Cash Provided By Used In Operating Activities -1426126.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20241231 Operating Lease Liability Current 47605.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Operating Lease Right Of Use Asset 46754.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Operating Right Of Use Asset1 -424.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20241231 Preferred Stock Shares Issued 25975.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Shares Outstanding 46025.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20250331 Property Plant And Equipment Net 9142.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Research And Development Expense 161166.0000 USD 1 us-gaap/2024 Business Segments= Facility And Other Overhead;
0001753926-25-000818 20250331 Research And Development Expense 399732.0000 USD 1 us-gaap/2024 Business Segments= Salaries And Benefits Insurance;
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock -94.0000 USD 1 0001753926-25-000818 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock USD 1 0001753926-25-000818
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock 30.0000 USD 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20231231 Shares Outstanding shares 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20231231 Stockholders Equity -10323843.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20240331 Stockholders Equity 14076843.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20240331 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20240331 Stock Issued During Period Shares Issued For Services 24510.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Stock Issued During Period Value Share Based Compensation 208639.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20240331 Stock Issued During Period Value Share Based Compensation USD 1 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20240331 Warrants Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20241231 Accounts Payable Current 388191.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Accrued Liabilities Current 258310.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 131152.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 2040149.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Common Stock Shares Issued 1208919.0000 shares 0 us-gaap/2024
0001753926-25-000818 20241231 Common Stock Value 121.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Common Stock Value 254.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Income Tax Expense Benefit USD 1 us-gaap/2024
0001753926-25-000818 20250331 Income Tax Expense Benefit USD 1 us-gaap/2024
0001753926-25-000818 20240331 Increase Decrease In Deferred Liabilities 576.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Interest Paid Net 6234.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Investment Income Interest 25837.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Net Of Issuance Costs USD 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Issuance Of Warrants To Purchase Series B Preferred Stock USD 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Liabilities And Stockholders Equity 4856051.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Net Cash Provided By Used In Operating Activities -1388438.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Operating Income Loss -1217646.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Operating Lease Liability Noncurrent USD 0 us-gaap/2024
0001753926-25-000818 20250331 Operating Lease Right Of Use Asset 23572.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20241231 Preferred Stock Shares Authorized 72000.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Shares Authorized 20000000.0000 shares 0 us-gaap/2024
0001753926-25-000818 20250331 Preferred Stock Shares Authorized 1050000.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Shares Issued 536959.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20241231 Preferred Stock Shares Outstanding 25975.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20241231 Preferred Stock Value 3.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20241231 Preferred Stock Value 30.0000 USD 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Value 5.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20241231 Prepaid Expense Current 347676.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Prepaid Expense Current 512696.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Research And Development Expense 206768.0000 USD 1 us-gaap/2024 Business Segments= Stock Option Expense;
0001753926-25-000818 20250331 Research And Development Expense 107708.0000 USD 1 us-gaap/2024 Business Segments= Facility And Other Overhead;
0001753926-25-000818 20250331 Research And Development Expense 486334.0000 USD 1 us-gaap/2024 Business Segments= Outsourced R And D;
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Retained Earnings;
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock Shares 972149.0000 shares 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock Shares 303041.0000 shares 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Shares Outstanding 46025.0000 shares 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Shares Outstanding 536959.0000 shares 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20231231 Stockholders Equity 3144448.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Stockholders Equity 20725522.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20240331 Warrants Converted To Common Stock -6.0000 USD 1 0001753926-25-000818 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20250331 Warrants Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Warrants Converted To Common Stock Shares 64702.0000 shares 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Accounts Payable Current 392115.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Additional Paid In Capital 17259406.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Assets 4856051.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 4225012.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Common Stock Shares Issued 2548811.0000 shares 0 us-gaap/2024
0001753926-25-000818 20240331 Depreciation Depletion And Amortization 721.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 General And Administrative Expense 1871.0000 USD 1 us-gaap/2024 Business Segments= Stock Option Expense;
0001753926-25-000818 20240331 Increase Decrease In Accrued Liabilities 7649.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Increase Decrease In Accrued Liabilities 20423.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Net Of Issuance Costs USD 1 0001753926-25-000818 Equity Components= Retained Earnings;
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Shares Net Of Issuance Costs 536959.0000 shares 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Operating Costs And Expenses 1457211.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Operating Lease Liability Noncurrent USD 0 us-gaap/2024
0001753926-25-000818 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20241231 Preferred Stock Shares Authorized 20000000.0000 shares 0 us-gaap/2024
0001753926-25-000818 20250331 Preferred Stock Shares Authorized 72000.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Shares Issued 46025.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001753926-25-000818 20250331 Preferred Stock Value 53.0000 USD 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock -30.0000 USD 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock Shares -303041.0000 shares 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20231231 Shares Outstanding shares 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20241231 Shares Outstanding 1208919.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20241231 Stockholders Equity 17259406.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20241231 Stockholders Equity 30.0000 USD 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Stockholders Equity 5.0000 USD 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20240331 Stock Issued During Period Value Issuance Of Common Stocks 4.0000 USD 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20240331 Stock Issued During Period Value Issuance Of Common Stocks USD 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20240331 Stock Issued During Period Value Issued For Services 200000.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Stock Issued During Period Value Issued For Services 199998.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20240331 Stock Issued During Period Value Share Based Compensation USD 1 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Warrants Converted To Common Stock USD 1 0001753926-25-000818
0001753926-25-000818 20250331 Accounts Receivable Net Current USD 0 us-gaap/2024
0001753926-25-000818 20250331 Research And Development Expense 993475.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Retained Earnings Accumulated Deficit -16646630.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Proceeds From Issuance Of Common Stock 3466275.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Common Stock Shares Outstanding 1208919.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20250331 Common Stock Shares Outstanding 134750.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A; Plan Name= Stock Option Plans2008;
0001753926-25-000818 20250331 Depreciation Depletion And Amortization 722.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Earnings Per Share Basic -1.3100 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1306523.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Interest Paid Net 4152.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Liabilities 776847.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Net Income Loss -1191809.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Net Income Loss -1191809.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20240331 Operating Costs And Expenses 1363526.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Operating Lease Right Of Use Asset 46754.0000 USD 0 us-gaap/2024 Finite Lived Intangible Assets By Major Class= Use Rights;
0001753926-25-000818 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock -3.0000 USD 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20241231 Shares Outstanding 303041.0000 shares 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Shares Outstanding 2548811.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20250331 Stockholders Equity -16646630.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20240331 Stock Issued During Period Value Issuance Of Common Stocks 200000.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20240331 Stock Issued During Period Value Issuance Of Common Stocks USD 1 0001753926-25-000818 Equity Components= Retained Earnings;
0001753926-25-000818 20240331 Stock Issued During Period Value Issued For Services USD 1 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Stock Issued During Period Value New Issues 382800.0000 USD 1 us-gaap/2024 Equity Components= Preferred Stock;
0001753926-25-000818 20240331 Warrants Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Warrants Converted To Common Stock -6.0000 USD 1 0001753926-25-000818 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20240331 Weighted Average Number Of Diluted Shares Outstanding 911515.0000 shares 1 us-gaap/2024
0001753926-25-000818 20250331 Assets Current 4823337.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -1188438.0000 USD 1 us-gaap/2024
0001753926-25-000818 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Furniture And Fixtures Gross 140294.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1191809.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Increase Decrease In Accounts Payable 3925.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Investment Income Interest 21298.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Net Of Issuance Costs 53.0000 USD 1 0001753926-25-000818 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20250331 Issuance Of Warrants To Purchase Series B Preferred Stock 9000.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20241231 Liabilities And Stockholders Equity 2673870.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Net Cash Provided By Used In Financing Activities 200000.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Net Income Loss -1306523.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20250331 Noncash Contribution Expense USD 1 us-gaap/2024
0001753926-25-000818 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Preferred Stock Shares Authorized 1050000.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20241231 Preferred Stock Shares Outstanding 303041.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20240331 Research And Development Expense 249766.0000 USD 1 us-gaap/2024 Business Segments= Outsourced R And D;
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock 0.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock 97.0000 USD 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Series B Preferred Stock Converted To Common Stock Shares -25975.0000 shares 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20250331 Series C Preferred Stock Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Retained Earnings;
0001753926-25-000818 20231231 Shares Outstanding 756745.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Shares Outstanding 879981.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Shares Outstanding shares 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20231231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20240331 Stockholders Equity 87.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20241231 Stockholders Equity 1919453.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Stockholders Equity 4079204.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Stock Issued During Period Value Issued For Services USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20240331 Stock Issued During Period Value Share Based Compensation 208639.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Warrants Converted To Common Stock USD 1 0001753926-25-000818
0001753926-25-000818 20240331 Warrants Converted To Common Stock Shares 62500.0000 shares 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Weighted Average Number Of Shares Outstanding Basic 2056804.0000 shares 1 us-gaap/2024
0001753926-25-000818 20241231 Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 130430.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Additional Paid In Capital 20725522.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Assets 2673870.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Cash And Cash Equivalents At Carrying Value 2184863.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Cash And Cash Equivalents At Carrying Value 4225012.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Common Stock Shares Authorized 200000000.0000 shares 0 us-gaap/2024
0001753926-25-000818 20250331 Common Stock Shares Issued 434750.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A; Plan Name= Stock Option Plans;
0001753926-25-000818 20241231 Common Stock Shares Outstanding 1208919.0000 shares 0 us-gaap/2024
0001753926-25-000818 20250331 General And Administrative Expense 92318.0000 USD 1 us-gaap/2024 Business Segments= Facility And Other Overhead;
0001753926-25-000818 20250331 General And Administrative Expense 142302.0000 USD 1 us-gaap/2024 Business Segments= Salaries And Benefits Insurance;
0001753926-25-000818 20250331 Grants Receivable Current 85630.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Income Taxes Paid Net USD 1 us-gaap/2024
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Net Of Issuance Costs 3457274.0000 USD 1 0001753926-25-000818
0001753926-25-000818 20250331 Issuance Of Preferred Stock And Warrants Net Of Issuance Costs 3457217.0000 USD 1 0001753926-25-000818 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20250331 Issuance Of Warrants To Purchase Series B Preferred Stock USD 1 0001753926-25-000818 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20241231 Liabilities 754417.0000 USD 0 us-gaap/2024
0001753926-25-000818 20241231 Liabilities Current 754417.0000 USD 0 us-gaap/2024
0001753926-25-000818 20250331 Liabilities Current 776846.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001753926-25-000818 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Noncash Contribution Expense 208639.0000 USD 1 us-gaap/2024
0001753926-25-000818 20240331 Nonoperating Income Expense 25837.0000 USD 1 us-gaap/2024
0001753926-25-000818 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001753926-25-000818 20241231 Preferred Stock Shares Issued 303041.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0001753926-25-000818 20241231 Retained Earnings Accumulated Deficit -15340107.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Shares Outstanding shares 0 us-gaap/2024 Equity Components= Series C Convertible Preferred Stocks;
0001753926-25-000818 20231231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Series B Convertible Preferred Stocks;
0001753926-25-000818 20240331 Stockholders Equity 2561278.0000 USD 0 us-gaap/2024
0001753926-25-000818 20240331 Stockholders Equity -11515652.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001753926-25-000818 20250331 Stockholders Equity 254.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Stock Issued During Period Shares Issuance Of Common Stocks 36227.0000 shares 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20240331 Stock Issued During Period Value Issued For Services 2.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20240331 Stock Issued During Period Value Share Based Compensation USD 1 us-gaap/2024 Equity Components= Common Stock;
0001753926-25-000818 20250331 Warrants Converted To Common Stock 6.0000 USD 1 0001753926-25-000818 Equity Components= Common Stock;
0001753926-25-000818 20250331 Warrants Converted To Common Stock USD 1 0001753926-25-000818 Equity Components= Retained Earnings;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment us-gaap/2024 0 0 monetary I C Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
Issuance Of Warrants To Purchase Series B Preferred Stock 0001753926-25-000818 1 0 monetary D C Issuance of warrants to purchase Series B preferred stock The element represents issuance of warrants to purchase series b preferred stock
Series B Preferred Stock Converted To Common Stock Shares 0001753926-25-000818 1 0 shares D Series B preferred stock converted to Common Stock (in shares) The element represents series b preferred stock converted to common stock shares
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued During Period Shares Issued For Services us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Increase Decrease In Grants Receivable 0001753926-25-000818 1 0 monetary D C Increase Decrease In Grants Receivable The element represents increase decrease in grants receivable
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Increase Decrease In Deferred Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Deferred Liabilities Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Prepaid Expense Current us-gaap/2024 0 0 monetary I D Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Value Share Based Compensation us-gaap/2024 0 0 monetary D C Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Warrants Converted To Common Stock 0001753926-25-000818 1 0 monetary D C Warrants exercised for Common Stock The element represents warrants converted to common stock
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Furniture And Fixtures Gross us-gaap/2024 0 0 monetary I D Furniture and Fixtures, Gross Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.
Increase Decrease In Prepaid Expense us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Payroll Liability 0001753926-25-000818 1 0 monetary I C Payroll liability The element represents payroll liability
Stock Issued During Period Value Issuance Of Common Stocks 0001753926-25-000818 1 0 monetary D C Issuance of Common Stock The element represents stock issued during period value issuance of common stocks
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Noncash Contribution Expense us-gaap/2024 0 0 monetary D D Noncash Contribution Expense Noncash charitable contributions made by the entity during the period.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Stock Issued During Period Value Issued For Services us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Issuance Of Preferred Stock And Warrants Net Of Issuance Costs 0001753926-25-000818 1 0 monetary D C Issuance of preferred stock and warrants, net of issuance costs of $382,800 The element represents issuance of preferred stock and warrants net of issuance costs
Warrants Converted To Common Stock Shares 0001753926-25-000818 1 0 shares D Warrants exercised for Common Stock (in shares) The element represents warrants converted to common stock shares
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Series B Preferred Stock Converted To Common Stock 0001753926-25-000818 1 0 monetary D C Series B preferred stock converted to Common Stock The element represents series b preferred stock converted to common stock
Stock Issued During Period Shares Issuance Of Common Stocks 0001753926-25-000818 1 0 shares D Issuance of Common Stock (in shares) The element represents stock issued during period shares issuance of common stocks
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Operating Right Of Use Asset1 0001753926-25-000818 1 0 monetary D D Operating right of use asset The element represents operating right of use asset1
Series C Preferred Stock Converted To Common Stock Shares 0001753926-25-000818 1 0 shares D Series C preferred stock converted to Common Stock (in shares) The element represents series c preferred stock converted to common stock shares
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Operating Costs And Expenses us-gaap/2024 0 0 monetary D D Operating Costs and Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Issuance Of Preferred Stock And Warrants Shares Net Of Issuance Costs 0001753926-25-000818 1 0 shares D Issuance of preferred stock and warrants, net of issuance costs of $382,800 (in shares) The element represents issuance of preferred stock and warrants shares net of issuance costs
Series C Preferred Stock Converted To Common Stock 0001753926-25-000818 1 0 monetary D C Series C preferred stock converted to Common Stock The element represents series c preferred stock converted to common stock
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Grants Receivable Current us-gaap/2024 0 0 monetary I D Grants Receivable, Current Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Increase Decrease In Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Issuance Of Stock And Warrants For Services Or Claims us-gaap/2024 0 0 monetary D D Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001753926-25-000818 2 8 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001753926-25-000818 2 9 BS 0 H Grants Receivable Current us-gaap/2024 Grants receivable 0
0001753926-25-000818 2 10 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts Receivable 0
0001753926-25-000818 2 11 BS 0 H Prepaid Expense Current us-gaap/2024 Prepaid expenses 0
0001753926-25-000818 2 12 BS 0 H Assets Current us-gaap/2024 Total Current Assets 0
0001753926-25-000818 2 13 BS 0 H Furniture And Fixtures Gross us-gaap/2024 Furniture, fixtures and equipment 0
0001753926-25-000818 2 14 BS 0 H Accumulated Depreciation Depletion And Amortization Property Plant And Equipment us-gaap/2024 Furniture, fixtures and equipment (accumulated depreciation) 1
0001753926-25-000818 2 15 BS 0 H Property Plant And Equipment Net us-gaap/2024 Furniture and fixtures, net 0
0001753926-25-000818 2 16 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right of use asset 0
0001753926-25-000818 2 17 BS 0 H Assets us-gaap/2024 Total Assets 0
0001753926-25-000818 2 18 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001753926-25-000818 2 19 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0001753926-25-000818 2 20 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease liability 0
0001753926-25-000818 2 21 BS 0 H Payroll Liability 0001753926-25-000818 Payroll liability 0
0001753926-25-000818 2 22 BS 0 H Liabilities Current us-gaap/2024 Total Current Liabilities 0
0001753926-25-000818 2 23 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liability, net of current portion 0
0001753926-25-000818 2 24 BS 0 H Liabilities us-gaap/2024 Total Liabilities 0
0001753926-25-000818 2 25 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock, value 0
0001753926-25-000818 2 26 BS 0 H Common Stock Value us-gaap/2024 Common stock, $0.0001 par value per share; 200,000,000 shares authorized, 2,548,811 shares issued and outstanding at March 31, 2025 and 1,208,919 shares issued and outstanding at December 31, 2024 0
0001753926-25-000818 2 27 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001753926-25-000818 2 28 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001753926-25-000818 2 29 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity 0
0001753926-25-000818 2 30 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders equity 0
0001753926-25-000818 3 7 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value 0
0001753926-25-000818 3 8 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0001753926-25-000818 3 9 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001753926-25-000818 3 10 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001753926-25-000818 3 11 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0001753926-25-000818 3 12 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001753926-25-000818 3 13 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares, issued 0
0001753926-25-000818 3 14 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares, outstanding 0
0001753926-25-000818 4 6 IS 0 H Revenues us-gaap/2024 Total revenues 0
0001753926-25-000818 4 7 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0001753926-25-000818 4 8 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001753926-25-000818 4 9 IS 0 H Operating Costs And Expenses us-gaap/2024 Total costs and expenses 0
0001753926-25-000818 4 10 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0001753926-25-000818 4 12 IS 0 H Investment Income Interest us-gaap/2024 Interest income, net 0
0001753926-25-000818 4 13 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income/(expense) 0
0001753926-25-000818 4 14 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Loss before income taxes 0
0001753926-25-000818 4 15 IS 0 H Income Tax Expense Benefit us-gaap/2024 Provision for income taxes 0
0001753926-25-000818 4 16 IS 0 H Net Income Loss us-gaap/2024 Net Loss 0
0001753926-25-000818 4 17 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic 0
0001753926-25-000818 4 18 IS 0 H Earnings Per Share Diluted us-gaap/2024 Dilutive 0
0001753926-25-000818 4 19 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Basic 0
0001753926-25-000818 4 20 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Dilutive 0
0001753926-25-000818 5 10 EQ 0 H Stockholders Equity us-gaap/2024 Beginning balance, value 0
0001753926-25-000818 5 11 EQ 0 H Shares Outstanding us-gaap/2024 Balance at beginning (in shares) 0
0001753926-25-000818 5 12 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001753926-25-000818 5 13 EQ 0 H Stock Issued During Period Value Share Based Compensation us-gaap/2024 Share based compensation 0
0001753926-25-000818 5 14 EQ 0 H Warrants Converted To Common Stock 0001753926-25-000818 Warrants exercised for Common Stock 0
0001753926-25-000818 5 15 EQ 0 H Warrants Converted To Common Stock Shares 0001753926-25-000818 Warrants exercised for Common Stock (in shares) 0
0001753926-25-000818 5 16 EQ 0 H Stock Issued During Period Value Issuance Of Common Stocks 0001753926-25-000818 Issuance of Common Stock 0
0001753926-25-000818 5 17 EQ 0 H Stock Issued During Period Shares Issuance Of Common Stocks 0001753926-25-000818 Issuance of Common Stock (in shares) 0
0001753926-25-000818 5 18 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Shares issued for services 0
0001753926-25-000818 5 19 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Shares issued for services (in shares) 0
0001753926-25-000818 5 20 EQ 0 H Series B Preferred Stock Converted To Common Stock 0001753926-25-000818 Series B preferred stock converted to Common Stock 0
0001753926-25-000818 5 21 EQ 0 H Series B Preferred Stock Converted To Common Stock Shares 0001753926-25-000818 Series B preferred stock converted to Common Stock (in shares) 0
0001753926-25-000818 5 22 EQ 0 H Series C Preferred Stock Converted To Common Stock 0001753926-25-000818 Series C preferred stock converted to Common Stock 0
0001753926-25-000818 5 23 EQ 0 H Series C Preferred Stock Converted To Common Stock Shares 0001753926-25-000818 Series C preferred stock converted to Common Stock (in shares) 0
0001753926-25-000818 5 24 EQ 0 H Issuance Of Warrants To Purchase Series B Preferred Stock 0001753926-25-000818 Issuance of warrants to purchase Series B preferred stock 0
0001753926-25-000818 5 25 EQ 0 H Issuance Of Preferred Stock And Warrants Net Of Issuance Costs 0001753926-25-000818 Issuance of preferred stock and warrants, net of issuance costs of $382,800 0
0001753926-25-000818 5 26 EQ 0 H Issuance Of Preferred Stock And Warrants Shares Net Of Issuance Costs 0001753926-25-000818 Issuance of preferred stock and warrants, net of issuance costs of $382,800 (in shares) 0
0001753926-25-000818 5 27 EQ 0 H Stockholders Equity us-gaap/2024 Ending balance, value 0
0001753926-25-000818 5 28 EQ 0 H Shares Outstanding us-gaap/2024 Balance at ending (in shares) 0
0001753926-25-000818 6 6 EQ 1 H Stock Issued During Period Value New Issues us-gaap/2024 Net of issurance costs 0
0001753926-25-000818 7 2 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001753926-25-000818 7 3 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001753926-25-000818 7 4 CF 0 H Issuance Of Stock And Warrants For Services Or Claims us-gaap/2024 Shares issued for services 0
0001753926-25-000818 7 5 CF 0 H Noncash Contribution Expense us-gaap/2024 Non-cash stock option expense 0
0001753926-25-000818 7 7 CF 0 H Operating Right Of Use Asset1 0001753926-25-000818 Operating right of use asset 0
0001753926-25-000818 7 8 CF 0 H Increase Decrease In Grants Receivable 0001753926-25-000818 Grants receivable 1
0001753926-25-000818 7 9 CF 0 H Increase Decrease In Prepaid Expense us-gaap/2024 Prepaid expense 1
0001753926-25-000818 7 10 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0001753926-25-000818 7 11 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued expenses 0
0001753926-25-000818 7 12 CF 0 H Increase Decrease In Deferred Liabilities us-gaap/2024 Payroll liability 0
0001753926-25-000818 7 13 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001753926-25-000818 7 15 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001753926-25-000818 7 17 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of Common Stock, net of issuance costs 0
0001753926-25-000818 7 18 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001753926-25-000818 7 19 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Net increase in cash, cash equivalents 0
0001753926-25-000818 7 20 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001753926-25-000818 7 21 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001753926-25-000818 7 23 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001753926-25-000818 7 24 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes paid 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.